The FDA has approved Wegovy for weight loss. It’s a higher-dose version of the same drug in Ozempic with the same active ...

Newly released data shows that the U.S. may have reached peak obesity in 2020 — and the timing unsurprisingly coincides with ...

Image credit In recent years, the search for natural solutions to support weight loss and overall health has led to the ...

Eli Lilly's weight-loss drug Zepbound and diabetes medication Mounjaro are no longer in short supply. That could limit ...

The San Francisco telehealth company had capitalized on the shortage by making copycat versions of popular brand-name GLP-1 ...

Eli Lilly's weight-loss drug Zepbound and diabetes drug Mounjaro are no longer in shortage, the U.S. Food and Drug ...

The U.S. Food and Drug Administration said Eli Lilly’s diabetes and weight-loss drugs marketed as Zepbound and Mounjaro are ...

Finding the right solution for weight loss can feel overwhelming, especially with so many options available. While ...

Wegovy and Zepbound are still hard to get. Knockoff versions from Noom, Ro, and others are filling in the gaps.

In real-world settings multiple factors contribute to non-persistence, including adverse effects, high cost-sharing and ...

Weight-loss drugs like Ozempic and Wegovy have become household names in recent years. But here's why they may not work for ...

Research shows patients taking weight-loss drugs like Ozempic and Wegovy are more likely to have food left in the stomach or ...